We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSD icon
2751
Invesco S&P Spin-Off ETF
CSD
$226M
$433K ﹤0.01%
8,677
-276
-3% -$13.9K
EVTC icon
2752
Evertec
EVTC
$1.77B
$431K ﹤0.01%
13,195
+219
+2% +$6.44K
EFR
2753
Eaton Vance Senior Floating-Rate Fund
EFR
$319M
$429K ﹤0.01%
32,757
-13,551
-29% -$180K
PGZ
2754
Principal Real Estate Income Fund
PGZ
$68.4M
$429K ﹤0.01%
22,545
+3,745
+20% +$70.5K
SIL icon
2755
Global X Silver Miners ETF NEW
SIL
$4.83B
$429K ﹤0.01%
16,003
-15
-0.1% -$367
MAGN
2756
Magnera Corp
MAGN
$466M
$429K ﹤0.01%
1,954
+35
+2% +$6.98K
NSTG
2757
DELISTED
NanoString Technologies, Inc.
NSTG
$429K ﹤0.01%
+14,149
New +$375K
CDTX
2758
DELISTED
Cidara Therapeutics
CDTX
$428K ﹤0.01%
12,750
-2,233
-15% -$92.8K
SYBT icon
2759
Stock Yards Bancorp
SYBT
$2.58B
$428K ﹤0.01%
11,827
+36
+0.3% +$1.25K
MOV icon
2760
Movado Group
MOV
$817M
$425K ﹤0.01%
15,759
+180
+1% +$5.66K
NVRI icon
2761
Enviri
NVRI
$615M
$425K ﹤0.01%
15,486
-5,979
-28% -$146K
SKX
2762
DELISTED
Skechers
SKX
$425K ﹤0.01%
13,487
+3,043
+29% +$93.9K
FTLS icon
2763
First Trust Long/Short Equity ETF
FTLS
$2.49B
$424K ﹤0.01%
10,526
-3,811
-27% -$151K
QCLN icon
2764
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$619M
$424K ﹤0.01%
20,069
+88
+0.4% +$1.8K
MPX
2765
DELISTED
Marine Products Corp
MPX
$423K ﹤0.01%
27,387
+4,948
+22% +$73.2K
PKB icon
2766
Invesco Building & Construction ETF
PKB
$393M
$423K ﹤0.01%
13,652
-473
-3% -$14K
QTS
2767
DELISTED
QTS REALTY TRUST, INC.
QTS
$423K ﹤0.01%
9,160
-778
-8% -$35.4K
HF
2768
DELISTED
HFF Inc.
HF
$423K ﹤0.01%
9,290
-188,473
-95% -$8.63M
MNKD icon
2769
MannKind Corp
MNKD
$1.26B
$422K ﹤0.01%
367,156
+1,894
+0.5% +$2.62K
JPT
2770
DELISTED
Nuveen Preferred and Income Fund
JPT
$422K ﹤0.01%
17,241
-11,500
-40% -$271K
LKFN icon
2771
Lakeland Financial Corp
LKFN
$1.52B
$421K ﹤0.01%
8,981
-1,316
-13% -$61.3K
OBK icon
2772
Origin Bancorp
OBK
$1.64B
$421K ﹤0.01%
12,772
-2,782
-18% -$94.5K
ECON icon
2773
Columbia Emerging Markets Consumer ETF
ECON
$303M
$419K ﹤0.01%
18,373
-2,451
-12% -$55.2K
HIO
2774
Western Asset High Income Opportunity Fund
HIO
$338M
$419K ﹤0.01%
81,660
-2,827
-3% -$14K
SCHC icon
2775
Schwab International Small-Cap Equity ETF
SCHC
$5.63B
$419K ﹤0.01%
12,822
-538
-4% -$17.4K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.